Heartbeam Stock Alpha and Beta Analysis

BEAT Stock  USD 3.06  0.21  7.37%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Heartbeam. It also helps investors analyze the systematic and unsystematic risks associated with investing in Heartbeam over a specified time horizon. Remember, high Heartbeam's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Heartbeam's market risk premium analysis include:
Beta
1.14
Alpha
0.44
Risk
4.69
Sharpe Ratio
0.12
Expected Return
0.57
Please note that although Heartbeam alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Heartbeam did 0.44  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Heartbeam stock's relative risk over its benchmark. Heartbeam has a beta of 1.14  . Heartbeam returns are very sensitive to returns on the market. As the market goes up or down, Heartbeam is expected to follow. At this time, Heartbeam's Tangible Book Value Per Share is comparatively stable compared to the past year. Enterprise Value Over EBITDA is likely to gain to 49.15 in 2024, whereas Book Value Per Share is likely to drop 0.74 in 2024.

Enterprise Value

45.95 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Heartbeam Backtesting, Heartbeam Valuation, Heartbeam Correlation, Heartbeam Hype Analysis, Heartbeam Volatility, Heartbeam History and analyze Heartbeam Performance.
For more information on how to buy Heartbeam Stock please use our How to Invest in Heartbeam guide.

Heartbeam Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Heartbeam market risk premium is the additional return an investor will receive from holding Heartbeam long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Heartbeam. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Heartbeam's performance over market.
α0.44   β1.14

Heartbeam expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Heartbeam's Buy-and-hold return. Our buy-and-hold chart shows how Heartbeam performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Heartbeam Market Price Analysis

Market price analysis indicators help investors to evaluate how Heartbeam stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Heartbeam shares will generate the highest return on investment. By understating and applying Heartbeam stock market price indicators, traders can identify Heartbeam position entry and exit signals to maximize returns.

Heartbeam Return and Market Media

The median price of Heartbeam for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 is 2.3 with a coefficient of variation of 9.11. The daily time series for the period is distributed with a sample standard deviation of 0.21, arithmetic mean of 2.34, and mean deviation of 0.16. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Disposition of 1674 shares by De Urioste George of Heartbeam at 2.34 subject to Rule 16b-3
09/06/2024
2
Insider Trading
09/09/2024
3
Heres Why Were Watching HeartBeams Cash Burn Situation
09/19/2024
4
HeartBeam Named Rising Star at the 6th Annual Digital Health Hub Foundation Awards
10/24/2024
5
HeartBeam to Host Third Quarter 2024 Results Conference Call on Thursday, November 7, 2024 at 430 p.m. Eastern Time
10/31/2024
6
The Nursing Beat Secures Equity Funding to Amplify Nurses Voices and Transform Healthcare News
11/07/2024
7
Disposition of 5000 shares by De Urioste George of Heartbeam at 2.46 subject to Rule 16b-3
11/08/2024
8
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
11/19/2024
9
Personal Care Stocks Q3 In Review BeautyHealth Vs Peers
11/26/2024

About Heartbeam Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Heartbeam or other stocks. Alpha measures the amount that position in Heartbeam has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2017 2018 2023 2024 (projected)
Payables Turnover8.658.219.448.48
Days Of Inventory On Hand17.0117.9416.1513.47

Heartbeam Upcoming Company Events

As portrayed in its financial statements, the presentation of Heartbeam's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Heartbeam's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Heartbeam's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Heartbeam. Please utilize our Beneish M Score to check the likelihood of Heartbeam's management manipulating its earnings.
21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Heartbeam

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Heartbeam Stock Analysis

When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.